Your browser doesn't support javascript.
loading
Optimized Therapeutic 177Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer.
Wu, Yitian; Zhang, Xiaojun; Duan, Xiaojiang; Yang, Xing; Wang, Feng; Zhang, Jinming.
Afiliação
  • Wu Y; Department of Nuclear Medicine, Chinese PLA General Hospital, Beijing 100853, China.
  • Zhang X; Department of Nuclear Medicine, Chinese PLA General Hospital, Beijing 100853, China.
  • Duan X; Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
  • Yang X; Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
  • Wang F; Institute of Medical Technology, Peking University, Beijing 100191, China.
  • Zhang J; Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Pharmaceuticals (Basel) ; 15(12)2022 Dec 09.
Article em En | MEDLINE | ID: mdl-36558981

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China